David Drutz - May 24, 2022 Form 4 Insider Report for Altimmune, Inc. (ALT)

Role
Director
Signature
/s/ Kent A. Tapper, as Attorney-in-Fact
Stock symbol
ALT
Transactions as of
May 24, 2022
Transactions value $
$5,400
Form type
4
Date filed
5/25/2022, 07:00 PM
Previous filing
Feb 16, 2022
Next filing
Jun 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALT Common Stock, par value $0.0001 Purchase $5.4K +1.2K +6.74% $4.50 19K May 24, 2022 Direct
holding ALT Common Stock, par value $0.0001 333 May 24, 2022 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Common Stock held by Pacific Biopharma Associates, LLC, of which the reporting person is the President.

Remarks:

Exhibit 24 - Power of Attorney